Skip to main content
. 2016 Jul 18;16:494. doi: 10.1186/s12885-016-2515-7

Table 2.

Overview of clinical parameters and relative serum expression of MMP7, MMP10 and MMP12

Patient Characteristics N Median relative serum expression
MMP7 p MMP10 P MMP12 p
Gender 0.049 0.138 0.004
 Male 51 1.21 1.22 1.19
 Female 24 0.97 0.95 0.88
Age at operation 0.013 0.003 0.253
 <median = 64 years 37 0.95 0.95 1.16
 ≥ median = 64 years 38 1.2 1.36 1.03
T-Stage 0.582 0.957 0.481
 T1 2 0.86 0.9 0.42
 T2 8 0.92 1.13 1.11
 T3 53 1.08 1.13 1.07
 T4 13 1.24 1.22 1.19
N-Stage 0.806 0.074 0.301
 Node negative 29 1.06 1.22 1.0
 Node positive 46 1.16 0.99 1.14
M-Stage 0.244 0.603 0.087
 M0 55 1.06 1.13 1.0
 M1 23 1.26 1.13 1.19
L-Stage 0.629 0.085 0.593
 L0 61 1.06 1.18 1.06
 L1 14 1.25 0.81 1.14
V-Stage 0.067 0.321 0.018
 V0 69 1.06 1.13 1.06
 V1 6 2.41 1.86 1.32
Micro satellite stage 0.053 0.845 0.844
 MSS 5 0.68 0.76 0.47
 MSI 2 1.16 0.95 1.01
Tumor site <0.001* 0.76 0.758
 Coecum 17 0.98 1.22 1.16
 Colon ascendens 14 1.11 0.88 0.78
 Right colon flexure 6 1.28 1.32 1.13
 Colon transversum 3 1.37 0.86 1.0
 Colon descendens 5 2.12 2.16 1.29
 Colon sigmoideum 30 0.96 0.99 1.14

*In ANOVA p < 0.001, the post-hoc Tukey’s test showed a significant difference between colon descendens and coecum, colon ascendens and right colon flexure (p < 0.001; p < 0.001; p = 0.007, respectively)

HHS Vulnerability Disclosure